 | • レポートコード：QYR2104Z4939 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、希少血液のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（組換え因子、血漿由来因子）、用途別市場規模（小児、成人）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・希少血液の市場動向 ・企業の競争状況、市場シェア ・希少血液の種類別市場規模（組換え因子、血漿由来因子） ・希少血液の用途別市場規模（小児、成人） ・希少血液の北米市場規模2016-2027（アメリカ、カナダ） ・希少血液のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・希少血液のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・希少血液の中南米市場規模2016-2027（メキシコ、ブラジル） ・希少血液の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Takeda、Novo Nordisk A/S、Pfizer Inc.、Bayer Healthcare AG、CSL Behring LLC、Biogen Inc.、Alexion Pharmaceuticals、Celgene Corporation、Amgen Inc.、PRA Health Sciences） ・結論 |
Market Analysis and Insights: Global Rare Hematology Market
The global Rare Hematology market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Rare Hematology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Rare Hematology market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Rare Hematology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Rare Hematology market.
Global Rare Hematology Scope and Market Size
Rare Hematology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Rare Hematology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Recombinant Factors
Plasma Derived Factors
Segment by Application
Pediatric
Adult
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Takeda
Novo Nordisk A/S
Pfizer Inc.
Bayer Healthcare AG
CSL Behring LLC
Biogen Inc.
Alexion Pharmaceuticals
Celgene Corporation
Amgen Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rare Hematology Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Recombinant Factors
1.2.3 Plasma Derived Factors
1.3 Market by Application
1.3.1 Global Rare Hematology Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pediatric
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Rare Hematology Market Perspective (2016-2027)
2.2 Rare Hematology Growth Trends by Regions
2.2.1 Rare Hematology Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Rare Hematology Historic Market Share by Regions (2016-2021)
2.2.3 Rare Hematology Forecasted Market Size by Regions (2022-2027)
2.3 Rare Hematology Industry Dynamic
2.3.1 Rare Hematology Market Trends
2.3.2 Rare Hematology Market Drivers
2.3.3 Rare Hematology Market Challenges
2.3.4 Rare Hematology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rare Hematology Players by Revenue
3.1.1 Global Top Rare Hematology Players by Revenue (2016-2021)
3.1.2 Global Rare Hematology Revenue Market Share by Players (2016-2021)
3.2 Global Rare Hematology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Rare Hematology Revenue
3.4 Global Rare Hematology Market Concentration Ratio
3.4.1 Global Rare Hematology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rare Hematology Revenue in 2020
3.5 Rare Hematology Key Players Head office and Area Served
3.6 Key Players Rare Hematology Product Solution and Service
3.7 Date of Enter into Rare Hematology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rare Hematology Breakdown Data by Type
4.1 Global Rare Hematology Historic Market Size by Type (2016-2021)
4.2 Global Rare Hematology Forecasted Market Size by Type (2022-2027)
5 Rare Hematology Breakdown Data by Application
5.1 Global Rare Hematology Historic Market Size by Application (2016-2021)
5.2 Global Rare Hematology Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Rare Hematology Market Size (2016-2027)
6.2 North America Rare Hematology Market Size by Type
6.2.1 North America Rare Hematology Market Size by Type (2016-2021)
6.2.2 North America Rare Hematology Market Size by Type (2022-2027)
6.2.3 North America Rare Hematology Market Size by Type (2016-2027)
6.3 North America Rare Hematology Market Size by Application
6.3.1 North America Rare Hematology Market Size by Application (2016-2021)
6.3.2 North America Rare Hematology Market Size by Application (2022-2027)
6.3.3 North America Rare Hematology Market Size by Application (2016-2027)
6.4 North America Rare Hematology Market Size by Country
6.4.1 North America Rare Hematology Market Size by Country (2016-2021)
6.4.2 North America Rare Hematology Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Rare Hematology Market Size (2016-2027)
7.2 Europe Rare Hematology Market Size by Type
7.2.1 Europe Rare Hematology Market Size by Type (2016-2021)
7.2.2 Europe Rare Hematology Market Size by Type (2022-2027)
7.2.3 Europe Rare Hematology Market Size by Type (2016-2027)
7.3 Europe Rare Hematology Market Size by Application
7.3.1 Europe Rare Hematology Market Size by Application (2016-2021)
7.3.2 Europe Rare Hematology Market Size by Application (2022-2027)
7.3.3 Europe Rare Hematology Market Size by Application (2016-2027)
7.4 Europe Rare Hematology Market Size by Country
7.4.1 Europe Rare Hematology Market Size by Country (2016-2021)
7.4.2 Europe Rare Hematology Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Rare Hematology Market Size (2016-2027)
8.2 Asia-Pacific Rare Hematology Market Size by Type
8.2.1 Asia-Pacific Rare Hematology Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Rare Hematology Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Rare Hematology Market Size by Type (2016-2027)
8.3 Asia-Pacific Rare Hematology Market Size by Application
8.3.1 Asia-Pacific Rare Hematology Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Rare Hematology Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Rare Hematology Market Size by Application (2016-2027)
8.4 Asia-Pacific Rare Hematology Market Size by Region
8.4.1 Asia-Pacific Rare Hematology Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Rare Hematology Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Rare Hematology Market Size (2016-2027)
9.2 Latin America Rare Hematology Market Size by Type
9.2.1 Latin America Rare Hematology Market Size by Type (2016-2021)
9.2.2 Latin America Rare Hematology Market Size by Type (2022-2027)
9.2.3 Latin America Rare Hematology Market Size by Type (2016-2027)
9.3 Latin America Rare Hematology Market Size by Application
9.3.1 Latin America Rare Hematology Market Size by Application (2016-2021)
9.3.2 Latin America Rare Hematology Market Size by Application (2022-2027)
9.3.3 Latin America Rare Hematology Market Size by Application (2016-2027)
9.4 Latin America Rare Hematology Market Size by Country
9.4.1 Latin America Rare Hematology Market Size by Country (2016-2021)
9.4.2 Latin America Rare Hematology Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rare Hematology Market Size (2016-2027)
10.2 Middle East & Africa Rare Hematology Market Size by Type
10.2.1 Middle East & Africa Rare Hematology Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Rare Hematology Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Rare Hematology Market Size by Type (2016-2027)
10.3 Middle East & Africa Rare Hematology Market Size by Application
10.3.1 Middle East & Africa Rare Hematology Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Rare Hematology Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Rare Hematology Market Size by Application (2016-2027)
10.4 Middle East & Africa Rare Hematology Market Size by Country
10.4.1 Middle East & Africa Rare Hematology Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Rare Hematology Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Rare Hematology Introduction
11.1.4 Takeda Revenue in Rare Hematology Business (2016-2021)
11.1.5 Takeda Recent Development
11.2 Novo Nordisk A/S
11.2.1 Novo Nordisk A/S Company Details
11.2.2 Novo Nordisk A/S Business Overview
11.2.3 Novo Nordisk A/S Rare Hematology Introduction
11.2.4 Novo Nordisk A/S Revenue in Rare Hematology Business (2016-2021)
11.2.5 Novo Nordisk A/S Recent Development
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Company Details
11.3.2 Pfizer Inc. Business Overview
11.3.3 Pfizer Inc. Rare Hematology Introduction
11.3.4 Pfizer Inc. Revenue in Rare Hematology Business (2016-2021)
11.3.5 Pfizer Inc. Recent Development
11.4 Bayer Healthcare AG
11.4.1 Bayer Healthcare AG Company Details
11.4.2 Bayer Healthcare AG Business Overview
11.4.3 Bayer Healthcare AG Rare Hematology Introduction
11.4.4 Bayer Healthcare AG Revenue in Rare Hematology Business (2016-2021)
11.4.5 Bayer Healthcare AG Recent Development
11.5 CSL Behring LLC
11.5.1 CSL Behring LLC Company Details
11.5.2 CSL Behring LLC Business Overview
11.5.3 CSL Behring LLC Rare Hematology Introduction
11.5.4 CSL Behring LLC Revenue in Rare Hematology Business (2016-2021)
11.5.5 CSL Behring LLC Recent Development
11.6 Biogen Inc.
11.6.1 Biogen Inc. Company Details
11.6.2 Biogen Inc. Business Overview
11.6.3 Biogen Inc. Rare Hematology Introduction
11.6.4 Biogen Inc. Revenue in Rare Hematology Business (2016-2021)
11.6.5 Biogen Inc. Recent Development
11.7 Alexion Pharmaceuticals
11.7.1 Alexion Pharmaceuticals Company Details
11.7.2 Alexion Pharmaceuticals Business Overview
11.7.3 Alexion Pharmaceuticals Rare Hematology Introduction
11.7.4 Alexion Pharmaceuticals Revenue in Rare Hematology Business (2016-2021)
11.7.5 Alexion Pharmaceuticals Recent Development
11.8 Celgene Corporation
11.8.1 Celgene Corporation Company Details
11.8.2 Celgene Corporation Business Overview
11.8.3 Celgene Corporation Rare Hematology Introduction
11.8.4 Celgene Corporation Revenue in Rare Hematology Business (2016-2021)
11.8.5 Celgene Corporation Recent Development
11.9 Amgen Inc.
11.9.1 Amgen Inc. Company Details
11.9.2 Amgen Inc. Business Overview
11.9.3 Amgen Inc. Rare Hematology Introduction
11.9.4 Amgen Inc. Revenue in Rare Hematology Business (2016-2021)
11.9.5 Amgen Inc. Recent Development
11.10 PRA Health Sciences
11.10.1 PRA Health Sciences Company Details
11.10.2 PRA Health Sciences Business Overview
11.10.3 PRA Health Sciences Rare Hematology Introduction
11.10.4 PRA Health Sciences Revenue in Rare Hematology Business (2016-2021)
11.10.5 PRA Health Sciences Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Rare Hematology Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Recombinant Factors
Table 3. Key Players of Plasma Derived Factors
Table 4. Global Rare Hematology Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Rare Hematology Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Rare Hematology Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Rare Hematology Market Share by Regions (2016-2021)
Table 8. Global Rare Hematology Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Rare Hematology Market Share by Regions (2022-2027)
Table 10. Rare Hematology Market Trends
Table 11. Rare Hematology Market Drivers
Table 12. Rare Hematology Market Challenges
Table 13. Rare Hematology Market Restraints
Table 14. Global Rare Hematology Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Rare Hematology Market Share by Players (2016-2021)
Table 16. Global Top Rare Hematology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rare Hematology as of 2020)
Table 17. Ranking of Global Top Rare Hematology Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Rare Hematology Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Rare Hematology Product Solution and Service
Table 21. Date of Enter into Rare Hematology Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Rare Hematology Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Rare Hematology Revenue Market Share by Type (2016-2021)
Table 25. Global Rare Hematology Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Rare Hematology Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Rare Hematology Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Rare Hematology Revenue Market Share by Application (2016-2021)
Table 29. Global Rare Hematology Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Rare Hematology Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Rare Hematology Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Rare Hematology Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Rare Hematology Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Rare Hematology Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Rare Hematology Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Rare Hematology Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Rare Hematology Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Rare Hematology Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Rare Hematology Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Rare Hematology Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Rare Hematology Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Rare Hematology Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Rare Hematology Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Rare Hematology Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Rare Hematology Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Rare Hematology Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Rare Hematology Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Rare Hematology Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Rare Hematology Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Rare Hematology Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Rare Hematology Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Rare Hematology Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Rare Hematology Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Rare Hematology Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Rare Hematology Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Rare Hematology Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Rare Hematology Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Rare Hematology Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Rare Hematology Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Rare Hematology Market Size by Country (2022-2027) & (US$ Million)
Table 61. Takeda Company Details
Table 62. Takeda Business Overview
Table 63. Takeda Rare Hematology Product
Table 64. Takeda Revenue in Rare Hematology Business (2016-2021) & (US$ Million)
Table 65. Takeda Recent Development
Table 66. Novo Nordisk A/S Company Details
Table 67. Novo Nordisk A/S Business Overview
Table 68. Novo Nordisk A/S Rare Hematology Product
Table 69. Novo Nordisk A/S Revenue in Rare Hematology Business (2016-2021) & (US$ Million)
Table 70. Novo Nordisk A/S Recent Development
Table 71. Pfizer Inc. Company Details
Table 72. Pfizer Inc. Business Overview
Table 73. Pfizer Inc. Rare Hematology Product
Table 74. Pfizer Inc. Revenue in Rare Hematology Business (2016-2021) & (US$ Million)
Table 75. Pfizer Inc. Recent Development
Table 76. Bayer Healthcare AG Company Details
Table 77. Bayer Healthcare AG Business Overview
Table 78. Bayer Healthcare AG Rare Hematology Product
Table 79. Bayer Healthcare AG Revenue in Rare Hematology Business (2016-2021) & (US$ Million)
Table 80. Bayer Healthcare AG Recent Development
Table 81. CSL Behring LLC Company Details
Table 82. CSL Behring LLC Business Overview
Table 83. CSL Behring LLC Rare Hematology Product
Table 84. CSL Behring LLC Revenue in Rare Hematology Business (2016-2021) & (US$ Million)
Table 85. CSL Behring LLC Recent Development
Table 86. Biogen Inc. Company Details
Table 87. Biogen Inc. Business Overview
Table 88. Biogen Inc. Rare Hematology Product
Table 89. Biogen Inc. Revenue in Rare Hematology Business (2016-2021) & (US$ Million)
Table 90. Biogen Inc. Recent Development
Table 91. Alexion Pharmaceuticals Company Details
Table 92. Alexion Pharmaceuticals Business Overview
Table 93. Alexion Pharmaceuticals Rare Hematology Product
Table 94. Alexion Pharmaceuticals Revenue in Rare Hematology Business (2016-2021) & (US$ Million)
Table 95. Alexion Pharmaceuticals Recent Development
Table 96. Celgene Corporation Company Details
Table 97. Celgene Corporation Business Overview
Table 98. Celgene Corporation Revenue in Rare Hematology Business (2016-2021) & (US$ Million)
Table 99. Celgene Corporation Recent Development
Table 100. Amgen Inc. Company Details
Table 101. Amgen Inc. Business Overview
Table 102. Amgen Inc. Rare Hematology Product
Table 103. Amgen Inc. Revenue in Rare Hematology Business (2016-2021) & (US$ Million)
Table 104. Amgen Inc. Recent Development
Table 105. PRA Health Sciences Company Details
Table 106. PRA Health Sciences Business Overview
Table 107. PRA Health Sciences Rare Hematology Product
Table 108. PRA Health Sciences Revenue in Rare Hematology Business (2016-2021) & (US$ Million)
Table 109. PRA Health Sciences Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rare Hematology Market Share by Type: 2020 VS 2027
Figure 2. Recombinant Factors Features
Figure 3. Plasma Derived Factors Features
Figure 4. Global Rare Hematology Market Share by Application: 2020 VS 2027
Figure 5. Pediatric Case Studies
Figure 6. Adult Case Studies
Figure 7. Rare Hematology Report Years Considered
Figure 8. Global Rare Hematology Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Rare Hematology Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Rare Hematology Market Share by Regions: 2020 VS 2027
Figure 11. Global Rare Hematology Market Share by Regions (2022-2027)
Figure 12. Global Rare Hematology Market Share by Players in 2020
Figure 13. Global Top Rare Hematology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rare Hematology as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Rare Hematology Revenue in 2020
Figure 15. Global Rare Hematology Revenue Market Share by Type (2016-2021)
Figure 16. Global Rare Hematology Revenue Market Share by Type (2022-2027)
Figure 17. North America Rare Hematology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Rare Hematology Market Share by Type (2016-2027)
Figure 19. North America Rare Hematology Market Share by Application (2016-2027)
Figure 20. North America Rare Hematology Market Share by Country (2016-2027)
Figure 21. United States Rare Hematology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Rare Hematology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Rare Hematology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Rare Hematology Market Share by Type (2016-2027)
Figure 25. Europe Rare Hematology Market Share by Application (2016-2027)
Figure 26. Europe Rare Hematology Market Share by Country (2016-2027)
Figure 27. Germany Rare Hematology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Rare Hematology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Rare Hematology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Rare Hematology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Rare Hematology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Rare Hematology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Rare Hematology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Rare Hematology Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Rare Hematology Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Rare Hematology Market Share by Region (2016-2027)
Figure 37. China Rare Hematology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Rare Hematology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Rare Hematology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Rare Hematology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Rare Hematology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Rare Hematology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Rare Hematology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Rare Hematology Market Share by Type (2016-2027)
Figure 45. Latin America Rare Hematology Market Share by Application (2016-2027)
Figure 46. Latin America Rare Hematology Market Share by Country (2016-2027)
Figure 47. Mexico Rare Hematology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Rare Hematology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Rare Hematology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Rare Hematology Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Rare Hematology Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Rare Hematology Market Share by Country (2016-2027)
Figure 53. Turkey Rare Hematology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Rare Hematology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Rare Hematology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Takeda Revenue Growth Rate in Rare Hematology Business (2016-2021)
Figure 57. Novo Nordisk A/S Revenue Growth Rate in Rare Hematology Business (2016-2021)
Figure 58. Pfizer Inc. Revenue Growth Rate in Rare Hematology Business (2016-2021)
Figure 59. Bayer Healthcare AG Revenue Growth Rate in Rare Hematology Business (2016-2021)
Figure 60. CSL Behring LLC Revenue Growth Rate in Rare Hematology Business (2016-2021)
Figure 61. Biogen Inc. Revenue Growth Rate in Rare Hematology Business (2016-2021)
Figure 62. Alexion Pharmaceuticals Revenue Growth Rate in Rare Hematology Business (2016-2021)
Figure 63. Celgene Corporation Revenue Growth Rate in Rare Hematology Business (2016-2021)
Figure 64. Amgen Inc. Revenue Growth Rate in Rare Hematology Business (2016-2021)
Figure 65. PRA Health Sciences Revenue Growth Rate in Rare Hematology Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
世界のヘマトロジー市場規模・現状・予測（2021年-2027年） In this report, we study the drugs for Hematology. Hematology is the science or study of blood, blood-forming organs and blood diseases. In the medical field, hematology includes the treatment of blood disorders and malignancies, including types of hemophilia, leukemia, lymphoma and sickle-cell anem…- 世界の希少血友病因子市場 2021：企業別、地域別、種類・用途別 The Rare Hemophilia Factors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 世界の血液治療市場規模・現状・予測（2021年-2027年） In this report, we study the drugs for Hematology. Hematology is the science or study of blood, blood-forming organs and blood diseases. In the medical field, hematology includes the treatment of blood disorders and malignancies, including types of hemophilia, leukemia, lymphoma and sickle-cell anem…
- 世界の血液治療市場規模・現状・予測（2021年-2027年） In this report, we study the drugs for Hematology. Hematology is the science or study of blood, blood-forming organs and blood diseases. In the medical field, hematology includes the treatment of blood disorders and malignancies, including types of hemophilia, leukemia, lymphoma and sickle-cell anem…
- 世界の希少神経疾患治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Rare Neurological Disease Treatment Market The global Rare Neurological Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and hig…